Takeda Pharmaceutical Newsroom

TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Announces Target Price $16

Futu NewsNov 19 16:36

Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)

TipRanksNov 19 14:54

TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating

Futu NewsNov 1 20:35

J.P. Morgan Maintains Takeda Pharmaceutical(TAK.US) With Hold Rating, Raises Target Price to $14.8

Futu NewsOct 10 20:31

Analysts Offer Insights on Healthcare Companies: Takeda Pharmaceutical Company (TAK), Amgen (AMGN) and Halozyme (HALO)

TipRanksOct 10 20:12

Takeda Pharmaceutical Buy Rating Justified by Strong Sales, Pipeline Advancements, and Reduced Risk

TipRanksAug 20 17:09

Analysts Conflicted on These Healthcare Names: CSL (OtherCMXHF), Pro Medicus Limited (OtherPMCUF) and Takeda Pharmaceutical Co (OtherTKPHF)

TipRanksAug 18 20:24

Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,000 Yen From 4,800 Yen, Keeps at Buy

MT NewswiresAug 12 17:59

Analysts Offer Insights on Healthcare Companies: Takeda Pharmaceutical Co (OtherTKPHF), Cerus (CERS) and Ultragenyx Pharmaceutical (RARE)

TipRanksAug 2 21:05

Jefferies Adjusts Takeda Pharmaceutical's Price Target to 4,800 Yen From 5,600 Yen, Keeps at Buy

MT NewswiresJul 31 17:45

Oppenheimer Cuts Ovid to Perform, Cites Uncertainty Over Lead Drug

Seeking AlphaJun 19 00:29

Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy

MT NewswiresFeb 13 16:41

Takeda Pharmaceutical Company (TAK) Receives a Hold From J.P. Morgan

TipRanksNov 28, 2023 20:16

Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy

MT NewswiresOct 3, 2023 17:49

Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy

MT NewswiresSep 22, 2023 19:30

Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy

MT NewswiresMay 31, 2023 17:59

TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating

MT NewswiresMay 16, 2023 21:16

TD Cowen Maintains Outperform on Takeda Pharmaceutical, Lowers Price Target to $20

BenzingaMay 16, 2023 19:19

TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating

MT NewswiresApr 4, 2023 20:27

TD Cowen Maintains Outperform on Takeda Pharmaceutical, Raises Price Target to $30

BenzingaApr 4, 2023 19:30